Skip to main content
Clinical Trials/NCT05888519
NCT05888519
Completed
Not Applicable

Evaluation of Safety and Tolerability of Investigational Ocular Lubricants

Alcon Research3 sites in 1 country47 target enrollmentStarted: July 24, 2023Last updated:
ConditionsDry Eye Disease

Overview

Phase
Not Applicable
Status
Completed
Enrollment
47
Locations
3
Primary Endpoint
Best corrected visual acuity (BCVA) with manifest refraction, at distance

Overview

Brief Summary

The purpose of this study is to evaluate investigational ocular lubricants for their safety and tolerability on subjects with mild to moderate dry eye disease.

Detailed Description

Subjects will be expected to attend a screening visit followed by 6 additional study visits. The expected duration of subject participation is approximately 3 weeks. This study will be conducted in Australia.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Sign an Informed Consent;
  • Have dry eye symptoms;
  • Other protocol-specified inclusion criteria may apply.

Exclusion Criteria

  • Ocular abnormalities;
  • Active ocular infection or inflammation not associated with dry eye;
  • History of ocular or intraocular surgery;
  • Other protocol-defined exclusion criteria may apply.

Outcomes

Primary Outcomes

Best corrected visual acuity (BCVA) with manifest refraction, at distance

Time Frame: Day 1, each wear period. A wear period is 1 day.

BCVA will be collected for each eye individually and recorded in logarithm Minimum Angle of Resolution (logMAR)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials